A detailed history of Hills Bank & Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Hills Bank & Trust CO holds 667 shares of AMGN stock, worth $193,363. This represents 0.02% of its overall portfolio holdings.

Number of Shares
667
Previous 654 1.99%
Holding current value
$193,363
Previous $204,000 4.9%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$309.38 - $337.38 $4,021 - $4,385
13 Added 1.99%
667 $214,000
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $10,510 - $12,772
40 Added 6.51%
654 $204,000
Q3 2023

Oct 26, 2023

SELL
$218.65 - $271.46 $1,311 - $1,628
-6 Reduced 0.97%
614 $165,000
Q1 2023

Apr 17, 2023

SELL
$225.79 - $275.2 $27,546 - $33,574
-122 Reduced 16.44%
620 $149,000
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $8,016 - $10,185
-35 Reduced 4.5%
742 $195,000
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 3.72%
777 $189,000
Q1 2022

Aug 16, 2022

SELL
$219.27 - $242.57 $2.2 Million - $2.43 Million
-10,036 Reduced 92.56%
807 $195,000
Q1 2022

Apr 29, 2022

BUY
$219.27 - $242.57 $2.18 Million - $2.41 Million
9,922 Added 1077.31%
10,843 $1.26 Million
Q4 2021

Feb 04, 2022

BUY
$198.88 - $227.6 $25,854 - $29,588
130 Added 16.43%
921 $208,000
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $4,245 - $4,974
20 Added 2.59%
791 $169,000
Q2 2021

Aug 02, 2021

SELL
$233.58 - $259.14 $934 - $1,036
-4 Reduced 0.52%
771 $188,000
Q1 2021

May 03, 2021

SELL
$221.91 - $258.6 $6,435 - $7,499
-29 Reduced 3.61%
775 $193,000
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $11,900 - $14,171
55 Added 7.34%
804 $185,000
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $1,173 - $1,304
-5 Reduced 0.66%
749 $191,000
Q2 2020

Aug 05, 2020

BUY
$197.81 - $242.74 $149,148 - $183,025
754 New
754 $178,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hills Bank & Trust CO Portfolio

Follow Hills Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hills Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hills Bank & Trust CO with notifications on news.